Vulnerability in Roche Accu-Chek Inform Ii
CVE-2018-18562
An issue was discovered in Roche Accu-Chek Inform II Base Unit / Base Unit Hub before 03.01.04 and CoaguChek / cobas h232 Handheld Base Unit before 03.01.04. Weak access credentials may enable attackers in the adjacent network to gain unauthorized service access via a service interface.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 8.8 (High). Vector: CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.007 (52.0th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 52nd percentile — 52.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.007 · newest: 0.007 · change: 0.000
Affected products
Weakness classification (CWE)
References
- ics-cert.us-cert.gov/advisories/ICSMA-18-310-01 (US Government Resource, Third Party Advisory, Mitigation)
- www.securityfocus.com/bid/105843 (VDB Entry, Third Party Advisory, vdb-entry)
Frequently asked questions
- What is CVE-2018-18562?
- CVE-2018-18562 is a high-severity vulnerability in Roche Accu-Chek Inform Ii, classified under Weak Password Requirements. CVSS score: 8.8/10. Published 2018-11-20.
- How severe is CVE-2018-18562?
- High severity. CVSS v3 base score is 8.8 out of 10.